Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A

Clinical Chemistry

Volumn 55, Issue 6, 2009, Pages 1214-1217

  Tertti, Risto ^a   Wittfooth, Saara ^b   Porela, Pekka ^a   Airaksinen, K E ^a   Metsärinne, Kaj ^a   Pettersson, Kim ^b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENOXAPARIN; HEPARIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG RESPONSE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION;

CORONARY ANGIOGRAPHY; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFUSIONS, INTRAVENOUS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; RENAL DIALYSIS;

EID: 66449111859     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.108738     Document Type: Article

References (19)

1. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr, et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 2001;345:1022-1029
2. Sangiorni G, Mauriello A, Bonanno E, Oxvig C, Conover CA, Christiansen M, et al. Pregnancy-associated plasma protein-A is markedly expressed by monocyte-macrophage cells in vulnerable and ruptured carotid atherosclerotic plaques. J Am Coll Cardiol 2006;47:2201-2211
3. Elesber AA, Lerman A, Denktas AE, Resch ZT, Bunch TJ, Schwartz RS, Conover CA. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol 2007;117:365-369 (Pubitemid 46507629)
4. Lund J, Qin Q-P, Ilva T, Pettersson K, Voipio-Pulkki L-M, Porela P, Pulkki K. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003;108:1924-1926 (Pubitemid 37296534)
5. Thorn EM, Khan IA. Pregnancy-associated plasma protein-A: an emerging cardiac biomarker. Int J Cardiol 2007;117:370-372 (Pubitemid 46507645)
6. Brügger-Andersen T, Hetland Ø, Pönitz V, Grundt H, Nilsen DWT. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thromb Res 2007;119:415-421
7. Terkelsen CJ, Oxvig C, Nørgaard BL, Glerup S, Poulsen TS, Lassen JF, et al. Temporal course of pregnancy-associated plasma protein-A in angioplasty-treated ST-elevation myocardial infarction patients and potential significance of concomitant heparin administration. Am J Cardiol 2009;103:29-35.
8. Qin Q-P, Kokkala S, Lund J, Tamm N, Voipio-Pulkki L-M, Pettersson K. Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 2005;51:75-83. (Pubitemid 40028321)
9. Kalousová M, Hořejši M, Fialová L, Sulková S, Malbohan I, Tesař V, Zima T. Increased levels of pregnancy-associated plasma protein A are associated with mortality in hemodialysis patients: preliminary results. Blood Purif 2004;22:298-300. (Pubitemid 39177735)
10. Lauzurica R, Pastor C, Bayés B, Hernández JM, Romero R. Pretransplant pregnancy-associated plasma protein-A as a predictor of chronic allograft nephropathy and posttransplant cardiovascular events. Transplantation 2005;80:1441-1446 (Pubitemid 41803627)
11. Kalousová M, Hodková M, Dusilová-Sulková S, Uhrová J, Tesař V, Zima T. Effect of hemodiafiltration on pregnancy-associated plasma protein A (PAPP-A) and related parameters. Ren Fail 2006;28:715-721 (Pubitemid 44950007)
12. Hertel J, Keep DM, Caruana RJ. Anticoagulation. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of dialysis. Philadelphia: Lippincott, Williams & Wilkins; 2001. p 182-198
13. Wittfooth S, Qin Q-P, Lund J, Tierala I, Pulkki K, Takalo H, Pettersson K. Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A. Clin Chem 2006;52:1794-1801 (Pubitemid 44330716)
14. Davey MW, Teisner B, Sinosich M, Grudzinskas JG. Interaction between heparin and human pregnancy-associated plasma protein A (PAPP-A): a simple purification procedure. Anal Biochem 1983;131:18-24.
15. Laursen LS, Overgaard MT, Weyer K, Boldt HB, Ebbesen P, Christiansen M, et al. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. J Biol Chem 2002;277:47225-47234
16. Baldus S, Rudolph V, Roiss M, Ito WD, Rudolph TK, Eiserich JP, et al. Heparins increase endothelial nitric oxidase bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006;113:1871-1878 (Pubitemid 43739399)
17. Näsström B, Stegmayr B, Gupta J, Olivecrona G, Olivecrona T. A single bolus of a low molecular weight heparin to patients on hemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing. Nephrol Dial Transplant 2005;20:1172-1179 (Pubitemid 40862107)
18. Boldt HB, Conover CA. Pregnancy-associated plasma protein-A (PAPP-A): a local regulator of IgF bioavailability through cleavage of IGFBPs. Growth Horm IGF Res 2007;17:10-18 (Pubitemid 46299994)
19. Iversen KK, Teisner AS, Teisner B, Kliem A, Thanning P, Grande P, Clemmensen P. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. Am J Cardiol 2008;101:1389-1394